Fig. 3From: A novel TLR4 binding protein, 40S ribosomal protein S3, has potential utility as an adjuvant in a dendritic cell-based vaccineMaturation and activation of human monocytic THP-1 cells and human dendritic cells by RPS3 proteinBack to article page